TapewireFind a company

person · Reporting owner

Sprague Suzanne

Disclosed activity across 1 company

Tapewire entity
60131
SEC CIK
0001914409

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
CME GROUP INC.CME · Entity 2909COO & Global Head of ClearingSeptember 15, 2026September 17, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

CME GROUP INC.

Report date September 15, 2026 · Filed September 17, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common Stock Class ASEC Table I · non-derivativeDirect15,548 Ending reported balance After 2026-09-16 transaction · row 5
5 source rows · reconciled sequence

Row 1 · 2026-09-15 · Grant · Acquired 2,864 · Balance 16,700

F1: Represents a grant of restricted stock under the CME Group Omnibus Stock Plan, vesting in four equal annual installments, subject to continued service.

Row 2 · 2026-09-15 · Tax withholding · Disposed 249 · Balance 16,451

F2: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person.

Row 3 · 2026-09-15 · Tax withholding · Disposed 275 · Balance 16,176

F2: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person.

Row 4 · 2026-09-15 · Tax withholding · Disposed 320 · Balance 15,856

F2: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person.

Row 5 · 2026-09-16 · Tax withholding · Disposed 308 · Balance 15,548

F2: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person.

Filing footnotes · ownership attribution and instrument terms

F1: Represents a grant of restricted stock under the CME Group Omnibus Stock Plan, vesting in four equal annual installments, subject to continued service.

F2: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
September 16, 2026 Filed Sep 17, 2026 20:26 UTC CME GROUP INC. CME · Entity 2909 Tax withholdingCommon Stock Class A 308 $272.46 $83,917.68
Disclosure

SEC source: 0001914409-26-000003 · wk-form4_1789676810.xml · nonDerivative · entry 5

Sprague Suzanne · CIK 0001914409 · COO & Global Head of Clearing

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,548

F2 · kind: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person.

Read SEC document
September 15, 2026 Filed Sep 17, 2026 20:26 UTC CME GROUP INC. CME · Entity 2909 Tax withholdingCommon Stock Class A 320 $275.09 $88,028.80
Disclosure

SEC source: 0001914409-26-000003 · wk-form4_1789676810.xml · nonDerivative · entry 4

Sprague Suzanne · CIK 0001914409 · COO & Global Head of Clearing

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,856

F2 · kind: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person.

Read SEC document
September 15, 2026 Filed Sep 17, 2026 20:26 UTC CME GROUP INC. CME · Entity 2909 Tax withholdingCommon Stock Class A 275 $275.09 $75,649.75
Disclosure

SEC source: 0001914409-26-000003 · wk-form4_1789676810.xml · nonDerivative · entry 3

Sprague Suzanne · CIK 0001914409 · COO & Global Head of Clearing

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,176

F2 · kind: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person.

Read SEC document
September 15, 2026 Filed Sep 17, 2026 20:26 UTC CME GROUP INC. CME · Entity 2909 Tax withholdingCommon Stock Class A 249 $275.09 $68,497.41
Disclosure

SEC source: 0001914409-26-000003 · wk-form4_1789676810.xml · nonDerivative · entry 2

Sprague Suzanne · CIK 0001914409 · COO & Global Head of Clearing

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,451

F2 · kind: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person.

Read SEC document
September 15, 2026 Filed Sep 17, 2026 20:26 UTC CME GROUP INC. CME · Entity 2909 GrantCommon Stock Class A 2,864 $275.09 $787,857.76
Disclosure

SEC source: 0001914409-26-000003 · wk-form4_1789676810.xml · nonDerivative · entry 1

Sprague Suzanne · CIK 0001914409 · COO & Global Head of Clearing

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,700

F1 · kind: Represents a grant of restricted stock under the CME Group Omnibus Stock Plan, vesting in four equal annual installments, subject to continued service.

Read SEC document
March 15, 2026 Filed Mar 17, 2026 16:23 UTC CME GROUP INC. CME · Entity 2909 Tax withholdingCommon Stock Class A 76 $311.40 $23,666.40
Disclosure

SEC source: 0001628280-26-018542 · wk-form4_1773764630.xml · nonDerivative · entry 3

Sprague Suzanne · CIK 0001914409 · COO & Global Head of Clearing

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,836

F3 · shares: Ms. Sprague surrendered shares to the company to fulfill tax withholding obligations upon the vesting of restricted stock on 3/15/2026.

Read SEC document
March 15, 2026 Filed Mar 17, 2026 16:23 UTC CME GROUP INC. CME · Entity 2909 Tax withholdingCommon Stock Class A 2,439 $311.40 $759,504.60
Disclosure

SEC source: 0001628280-26-018542 · wk-form4_1773764630.xml · nonDerivative · entry 2

Sprague Suzanne · CIK 0001914409 · COO & Global Head of Clearing

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,912

F2 · shares: Ms. Sprague surrendered shares to the company in order to fulfill tax withholding obligations related to the receipt of the performance share award.

Read SEC document
March 15, 2026 Filed Mar 17, 2026 16:23 UTC CME GROUP INC. CME · Entity 2909 GrantCommon Stock Class A 5,504 $311.40 $1,713,945.60
Disclosure

SEC source: 0001628280-26-018542 · wk-form4_1773764630.xml · nonDerivative · entry 1

Sprague Suzanne · CIK 0001914409 · COO & Global Head of Clearing

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,351

F1 · shares: Represents the vesting of performance shares granted in 2022 under CME Group's Omnibus Stock Plan. The number of shares was determined based on the company's achievement of total shareholder return relative to the S&P 500 measured over a three-year performance period from January 1, 2023 through December 31, 2025.

Read SEC document
September 16, 2025 Filed Sep 17, 2025 17:48 UTC CME GROUP INC. CME · Entity 2909 Tax withholdingCommon Stock Class A 325 $259.83 $84,444.75
Disclosure

SEC source: 0001914409-25-000005 · wk-form4_1758131336.xml · nonDerivative · entry 3

Sprague Suzanne · CIK 0001914409 · COO & Global Head of Clearing

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,847

F2 · shares: Ms. Sprague surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on September 16, 2025.

Read SEC document
September 15, 2025 Filed Sep 17, 2025 17:48 UTC CME GROUP INC. CME · Entity 2909 GrantCommon Stock Class A 3,044 $258.83 $787,878.52
Disclosure

SEC source: 0001914409-25-000005 · wk-form4_1758131336.xml · nonDerivative · entry 2

Sprague Suzanne · CIK 0001914409 · COO & Global Head of Clearing

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,172

Read SEC document
September 15, 2025 Filed Sep 17, 2025 17:48 UTC CME GROUP INC. CME · Entity 2909 Tax withholdingCommon Stock Class A 639 $258.83 $165,392.37
Disclosure

SEC source: 0001914409-25-000005 · wk-form4_1758131336.xml · nonDerivative · entry 1

Sprague Suzanne · CIK 0001914409 · COO & Global Head of Clearing

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,128

F1 · shares: Ms. Sprague surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on September 15, 2025.

Read SEC document
March 15, 2025 Filed Mar 18, 2025 16:18 UTC CME GROUP INC. CME · Entity 2909 Tax withholdingCommon Stock Class A 78 $258.68 $20,177.04
Disclosure

SEC source: 0001156375-25-000050 · wk-form4_1742314706.xml · nonDerivative · entry 5

Sprague Suzanne · CIK 0001914409 · COO & Global Head of Clearing

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,767

F4 · shares: Ms. Sprague surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 3/15/2025.

Read SEC document
March 15, 2025 Filed Mar 18, 2025 16:18 UTC CME GROUP INC. CME · Entity 2909 Tax withholdingCommon Stock Class A 491 $258.68 $127,011.88
Disclosure

SEC source: 0001156375-25-000050 · wk-form4_1742314706.xml · nonDerivative · entry 4

Sprague Suzanne · CIK 0001914409 · COO & Global Head of Clearing

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,845

F2 · shares: Ms. Sprague surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award.

Read SEC document
March 15, 2025 Filed Mar 18, 2025 16:18 UTC CME GROUP INC. CME · Entity 2909 GrantCommon Stock Class A 1,108 $258.68 $286,617.44
Disclosure

SEC source: 0001156375-25-000050 · wk-form4_1742314706.xml · nonDerivative · entry 3

Sprague Suzanne · CIK 0001914409 · COO & Global Head of Clearing

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,336

F3 · shares: Represents shares earned from a March 2022 performance share award based on the company's achievement of total shareholder return relative to the S&P 500 measured over 2022-2024.

Read SEC document
March 15, 2025 Filed Mar 18, 2025 16:18 UTC CME GROUP INC. CME · Entity 2909 Tax withholdingCommon Stock Class A 153 $258.68 $39,578.04
Disclosure

SEC source: 0001156375-25-000050 · wk-form4_1742314706.xml · nonDerivative · entry 2

Sprague Suzanne · CIK 0001914409 · COO & Global Head of Clearing

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,228

F2 · shares: Ms. Sprague surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award.

Read SEC document
March 15, 2025 Filed Mar 18, 2025 16:18 UTC CME GROUP INC. CME · Entity 2909 GrantCommon Stock Class A 345 $258.68 $89,244.60
Disclosure

SEC source: 0001156375-25-000050 · wk-form4_1742314706.xml · nonDerivative · entry 1

Sprague Suzanne · CIK 0001914409 · COO & Global Head of Clearing

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,381

F1 · shares: Represents shares earned from a 2021 performance share award based on the company's achievement of total shareholder return relative to the S&P 500 measured over 2022-2024.

Read SEC document
March 03, 2025 Filed Mar 4, 2025 19:11 UTC CME GROUP INC. CME · Entity 2909 SaleCommon Stock Class A 1,500 $256.83 $385,249.35
Disclosure

SEC source: 0001156375-25-000029 · wk-form4_1741115511.xml · nonDerivative · entry 1

Sprague Suzanne · CIK 0001914409 · COO & Global Head of Clearing

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,036

Read SEC document
September 16, 2024 Filed Sep 17, 2024 23:12 UTC CME GROUP INC. CME · Entity 2909 GrantCommon Stock Class A 3,088 $218.53 $674,820.64
Disclosure

SEC source: 0001156375-24-000180 · wk-form4_1726614714.xml · nonDerivative · entry 2

Sprague Suzanne · CIK 0001914409 · Sr MD Global Head of Clearing

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,536

Read SEC document
September 15, 2024 Filed Sep 17, 2024 23:12 UTC CME GROUP INC. CME · Entity 2909 Tax withholdingCommon Stock Class A 755 $216.99 $163,827.45
Disclosure

SEC source: 0001156375-24-000180 · wk-form4_1726614714.xml · nonDerivative · entry 1

Sprague Suzanne · CIK 0001914409 · Sr MD Global Head of Clearing

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,448

F1 · shares: Ms. Sprague surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on September 15, 2024.

Read SEC document
March 15, 2024 Filed Mar 19, 2024 15:23 UTC CME GROUP INC. CME · Entity 2909 Tax withholdingCommon Stock Class A 81 $217.50 $17,617.50
Disclosure

SEC source: 0001156375-24-000043 · wk-form4_1710861770.xml · nonDerivative · entry 3

Sprague Suzanne · CIK 0001914409 · Sr MD Global Head of Clearing

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,203

F3 · shares: Ms. Sprague surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 3/15/2024.

Read SEC document
March 15, 2024 Filed Mar 19, 2024 15:23 UTC CME GROUP INC. CME · Entity 2909 Tax withholdingCommon Stock Class A 249 $217.50 $54,157.50
Disclosure

SEC source: 0001156375-24-000043 · wk-form4_1710861770.xml · nonDerivative · entry 2

Sprague Suzanne · CIK 0001914409 · Sr MD Global Head of Clearing

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,284

F2 · shares: Ms. Sprague surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award.

Read SEC document
March 15, 2024 Filed Mar 19, 2024 15:23 UTC CME GROUP INC. CME · Entity 2909 GrantCommon Stock Class A 561 $217.50 $122,017.50
Disclosure

SEC source: 0001156375-24-000043 · wk-form4_1710861770.xml · nonDerivative · entry 1

Sprague Suzanne · CIK 0001914409 · Sr MD Global Head of Clearing

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,533

F1 · shares: Represents shares earned from a 2020 performance share award based on the company's achievement of total shareholder return relative to the S&P 500 measured over 2021-2023.

Read SEC document
October 31, 2023 Filed Nov 1, 2023 14:06 UTC CME GROUP INC. CME · Entity 2909 SaleCommon Stock Class A 1,146 $211.79 $242,711.34
Disclosure

SEC source: 0001156375-23-000185 · wk-form4_1698847606.xml · nonDerivative · entry 1

Sprague Suzanne · CIK 0001914409 · Sr MD Global Head of Clearing

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,972

Read SEC document
September 16, 2023 Filed Sep 18, 2023 22:15 UTC CME GROUP INC. CME · Entity 2909 Tax withholdingCommon Stock Class A 89 $206.82 $18,406.98
Disclosure

SEC source: 0001156375-23-000162 · wk-form4_1695075340.xml · nonDerivative · entry 3

Sprague Suzanne · CIK 0001914409 · Sr MD Global Head of Clearing

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,118

F2 · shares: Ms. Sprague surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/16/2023.

Read SEC document
September 15, 2023 Filed Sep 18, 2023 22:15 UTC CME GROUP INC. CME · Entity 2909 Tax withholdingCommon Stock Class A 481 $206.82 $99,480.42
Disclosure

SEC source: 0001156375-23-000162 · wk-form4_1695075340.xml · nonDerivative · entry 2

Sprague Suzanne · CIK 0001914409 · Sr MD Global Head of Clearing

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,207

F1 · shares: Ms. Sprague surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/15/2023.

Read SEC document
September 15, 2023 Filed Sep 18, 2023 22:15 UTC CME GROUP INC. CME · Entity 2909 GrantCommon Stock Class A 2,900 $206.82 $599,778.00
Disclosure

SEC source: 0001156375-23-000162 · wk-form4_1695075340.xml · nonDerivative · entry 1

Sprague Suzanne · CIK 0001914409 · Sr MD Global Head of Clearing

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,688

Read SEC document
March 15, 2023 Filed Mar 17, 2023 17:51 UTC CME GROUP INC. CME · Entity 2909 Tax withholdingCommon Stock Class A 171 $182.67 $31,236.57
Disclosure

SEC source: 0001156375-23-000038 · wf-form4_167907549724776.xml · nonDerivative · entry 1

Sprague Suzanne · CIK 0001914409 · Sr MD Global Head of Clearing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,788

F1 · shares: Ms. Suzanne Sprague surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 3/15/2023.

Read SEC document
September 16, 2022 Filed Sep 19, 2022 23:06 UTC CME GROUP INC. CME · Entity 2909 Tax withholdingCommon Stock Class A 94 $191.56 $18,006.64
Disclosure

SEC source: 0001156375-22-000286 · wf-form4_166362874484674.xml · nonDerivative · entry 3

Sprague Suzanne · CIK 0001914409 · Sr MD Global Head of Clearing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,959

F2 · shares: Ms. Suzanne Sprague surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/16/2022.

Read SEC document
September 15, 2022 Filed Sep 19, 2022 23:06 UTC CME GROUP INC. CME · Entity 2909 GrantCommon Stock Class A 2,752 $0.00 $0.00
Disclosure

SEC source: 0001156375-22-000286 · wf-form4_166362874484674.xml · nonDerivative · entry 2

Sprague Suzanne · CIK 0001914409 · Sr MD Global Head of Clearing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,053

Read SEC document
September 15, 2022 Filed Sep 19, 2022 23:06 UTC CME GROUP INC. CME · Entity 2909 Tax withholdingCommon Stock Class A 202 $190.77 $38,535.54
Disclosure

SEC source: 0001156375-22-000286 · wf-form4_166362874484674.xml · nonDerivative · entry 1

Sprague Suzanne · CIK 0001914409 · Sr MD Global Head of Clearing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,301

F1 · shares: Ms. Suzanne Sprague surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/15/2022.

Read SEC document
September 14, 2022 Filed Sep 15, 2022 21:49 UTC CME GROUP INC. CME · Entity 2909 Tax withholdingCommon Stock Class A 91 $0.00 $0.00
Disclosure

SEC source: 0001156375-22-000239 · wf-form4_166327854175109.xml · nonDerivative · entry 1

Sprague Suzanne · CIK 0001914409 · Sr MD Global Head of Clearing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,503

F1 · shares: Ms. Suzanne Sprague surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/14/2022.

Read SEC document
September 14, 2022 Filed Sep 19, 2022 23:08 UTC Amendment CME GROUP INC. CME · Entity 2909 Tax withholdingCommon Stock Class A 91 $191.30 $17,408.30
Disclosure

SEC source: 0001156375-22-000290 · wf-form4a_166362891298773.xml · nonDerivative · entry 1

Sprague Suzanne · CIK 0001914409 · Sr MD Global Head of Clearing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,503

F1 · shares: Ms. Suzanne Sprague surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/14/2022.

F2 · price: This Form 4 is being amended to include the price at which shares were withheld for payment of taxes, which amount was inadvertently omitted from the original filing due to clerical error.

Read SEC document
March 15, 2022 Filed Mar 17, 2022 20:43 UTC CME GROUP INC. CME · Entity 2909 GrantCommon Stock Class A 1,020 $232.00 $236,640.00
Disclosure

SEC source: 0001156375-22-000131 · wf-form4_164754978486082.xml · nonDerivative · entry 3

Sprague Suzanne · CIK 0001914409 · Sr MD Global Head of Clearing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,594

F3 · shares: On March 15, 2022, the reporting person was granted restricted shares, vesting in four equal annual installments on the first four anniversaries of the grant date, subject to the restricted share agreement.

Read SEC document
March 15, 2022 Filed Mar 17, 2022 20:43 UTC CME GROUP INC. CME · Entity 2909 Tax withholdingCommon Stock Class A 66 $232.00 $15,312.00
Disclosure

SEC source: 0001156375-22-000131 · wf-form4_164754978486082.xml · nonDerivative · entry 2

Sprague Suzanne · CIK 0001914409 · Sr MD Global Head of Clearing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,574

F2 · shares: Ms. Sprague surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award.

Read SEC document
March 15, 2022 Filed Mar 17, 2022 20:43 UTC CME GROUP INC. CME · Entity 2909 GrantCommon Stock Class A 222 $232.00 $51,504.00
Disclosure

SEC source: 0001156375-22-000131 · wf-form4_164754978486082.xml · nonDerivative · entry 1

Sprague Suzanne · CIK 0001914409 · Sr MD Global Head of Clearing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,640

F1 · shares: Represents shares earned from a 2018 performance share award based on the company's achievement of total shareholder return relative to the S&P 500 measured over 2019-2021.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.